Applying Svejgaard and Ryder analysis [19], we noticed that the heterozygosity of rs2234167 (HVEM) and rs2231375 (CD160) significantly increased the risk of ccRCC. The gene discussed is CD160; the disease is nonpapillary renal cell carcinoma.